The Raxibacumab Injection, cataloged under National Stock Number 6505-01-686-9526, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Virology, Llc Div Emergent Virology. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-686-9526 |
| Primary Part Number | NDC71655-0103-01 |
| Item Name | Raxibacumab Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Virology, Llc Div Emergent Virology |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC71655-0103-01 PRIMARY | Emergent Virology, Llc Div Emergent Virology (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM206008 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1569903 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-686-9526 is a Raxibacumab Injection, manufactured by Emergent Virology, Llc Div Emergent Virology, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-686-9526 has 1 manufacturer part number on file: NDC71655-0103-01 (Emergent Virology, Llc Div Emergent Virology).
Key specifications for NDC71655-0103-01: Special Features: INDICATED FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH INHALATIONAL ANTHRAX DUE TO BACILLUS ANTHRACIS IN CONBINATION WITH APPROPRIATE ANTIBACTERIAL DRUGS, AND FOR PROPHYLAXIS OF INHALATIONAL ANTHRAX WHEN ALTERNATIVE THERAPIES ARE NOT AVAILABLE OR ARE NOT APPROPRIATE; FOR INTRAVENOUS INFUSION; MUST BE DILUTED PRIOR TO USE; SINGLE-USE VIAL; DISCARD UNUSED PORTION; TWO VIALS PER DOSE; MUST BE REFRIGERATED AT 2C TO 8C(36F TO 46F); DO NOT FREEZE; PROTECT THE VIAL FROM EXPOSURE TO LIGHT, PRIOR TO USE; BRIEF EXPOSURE TO LIGHT, AS WITH NORMAL USE, IS ACCEPTABLE; STORE VIAL IN ORIGINAL CARTON UNTIL TIME OF USE. 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL.; Part Name Assigned by Controlling Agency: RAXIBACUMAB INJECTION 1,700 MG/34 ML (50 MG/ML) SINGLE USE VIAL. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.